Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Biosensors
      • Chromatography
      • Flow Cytometry
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register

What are ion mobility MS and collision cross section data?

10 Oct 2017
MS (LC–MS/MS, HRMS, IMS)

Learn about the fundamentals of ion mobility mass spectrometry (IMS) and the benefits of collisional-cross section (CCS) data.


To learn more about Waters and their products please click here.

Top content

  • Editor’s highlights from NextGen Biomed 2026
  • Validation of a 25-color spectral flow cytometry assay for immunoprofiling of human whole blood samples from clinical trials
  • New DNA system strikes cancer with precision

Related tags

ion ion mobility spectrometry MS
Previous article Next article

Related articles

8 MAY 2012 DATA PROCESSING AND INTERPRETATION
Development of a method by UPLC–MS/MS for the quantification of tizoxanide in human plasma and its pharmacokinetic application
27 OCT 2021 NEWS
MOBIE ion separation instrument to debut at 69th American Society for Mass Spectrometry conference
16 JUN 2011 CLINICAL
Research Spotlight: Biospectroscopy at the Manchester Interdisciplinary Biocentre
27 JUN 2016 NEWS
SWATH-MS aids leap towards personalized medicine
10 OCT 2019 GENERAL INTEREST
The step into high-resolution quantification for bioanalysis
9 MAY 2012 DATA PROCESSING AND INTERPRETATION
Recent advances in metabolite identification and quantitative bioanalysis by LC–Q-TOF MS
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility
  • Editorial Policies

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2026 Bioanalysis Zone